BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 33672129)

  • 1. Neuroinflammation in Prion Disease.
    Li B; Chen M; Zhu C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia in prion diseases.
    Aguzzi A; Zhu C
    J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Microglial Inflammation in Prion Disease.
    Ano Y; Sakudo A; Onodera T
    Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia in Prion Diseases: Angels or Demons?
    Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
    Carroll JA; Chesebro B
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement 3
    Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
    Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation in prion diseases: concepts and targets for therapeutic intervention.
    Riemer C; Gültner S; Heise I; Holtkamp N; Baier M
    CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):329-41. PubMed ID: 19702571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
    Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
    Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuroprotective role for microglia in prion diseases.
    Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
    J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases.
    Kushwaha R; Sinha A; Makarava N; Molesworth K; Baskakov IV
    Acta Neuropathol Commun; 2021 Feb; 9(1):22. PubMed ID: 33546775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD11c is not required by microglia to convey neuroprotection after prion infection.
    Carroll JA; Striebel JF; Baune C; Chesebro B; Race B
    PLoS One; 2023; 18(11):e0293301. PubMed ID: 37910561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation.
    Thellung S; Villa V; Corsaro A; Pellistri F; Venezia V; Russo C; Aceto A; Robello M; Florio T
    Glia; 2007 Nov; 55(14):1469-85. PubMed ID: 17705195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
    Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
    Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytic Activities of Reactive Microglia and Astrocytes Associated with Prion Diseases Are Dysregulated in Opposite Directions.
    Sinha A; Kushwaha R; Molesworth K; Mychko O; Makarava N; Baskakov IV
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroglial patterns are shared by cerebella from prion and prion-like disorder affected patients.
    Garcés M; Guijarro MI; Vargas A; Badiola JJ; Monzón M
    Mech Ageing Dev; 2019 Dec; 184():111176. PubMed ID: 31689427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?
    Tiwari RK; Moin A; Rizvi SMD; Shahid SMA; Bajpai P
    Metab Brain Dis; 2021 Jun; 36(5):829-847. PubMed ID: 33704660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.
    Zhu C; Herrmann US; Li B; Abakumova I; Moos R; Schwarz P; Rushing EJ; Colonna M; Aguzzi A
    Neurobiol Aging; 2015 May; 36(5):1994-2003. PubMed ID: 25816748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis.
    Li B; Chen M; Aguzzi A; Zhu C
    J Mol Med (Berl); 2021 Jun; 99(6):877-887. PubMed ID: 33758958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.